ValentinaBoni7

发表

Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade

J. Machiels, K. Korski, G. Meneses‐Lorente, 2022, Journal for ImmunoTherapy of Cancer.